Board Meeting20 May 2026, 06:11 pm
Mahamaya Lifesciences Board Meeting on May 25, 2026
AI Summary
Mahamaya Lifesciences Ltd has scheduled a Board of Directors meeting on May 25, 2026, to consider and approve the audited standalone and consolidated financial results for the half year and financial year ended March 31, 2026, along with the audit reports. The trading window remains closed until 48 hours after the declaration of the financial results, as per the company's Insider Trading Code and SEBI regulations.
Key Highlights
- Board meeting scheduled for May 25, 2026, to approve financial results.
- Audited standalone and consolidated results for FY26 to be considered.
- Trading window closed until 48 hours post results declaration.
- Meeting is pursuant to Regulation 29(1) of SEBI Listing Regulations.
Price Impact
More from MAHALIFE